Clinical trial data key to personalization of treatment decisions
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
We push the boundaries of finance to solve complex problems and fuel progress in the world through the MIT finance ecosystem – a unique global network of people, programs, research, and partnerships.
By
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).
By
Generative artificial intelligence can help designers come up with new ideas, according to a new study.
About the MIT Applied Cooperation Initiative
We are a small but mighty team dedicated to helping MIT students develop as dynamic leaders equipped to collaborate with others to solve the world’s most pressing problems.
Leadership at MIT is not a title or a person. It’s a process. We begin with self-awareness and combine science-based frameworks, personalized coaching, and practical applications to develop leaders.
Here, leadership is not a title or a person. It’s a process. We begin with self-awareness, then combine science-based frameworks, personalized coaching, and practical applications to develop leaders.
Ahead of the presidential inauguration, MIT Sloan's Professor Andrew Lo and other panelists described advances in their research and how these discoveries are being deployed to benefit the public.